Abstract Background Drug resistance continues to be a major limiting factor across diverse anti-cancer therapies. Contributing to the complexity of this challenge is cancer plasticity. in which one cancer subtype switches to another in response to treatment. for example. https://parisnaturalfoodes.shop/product-category/dmae-advanced-firming-cream/